Gallus Biopharmaceuticals Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
180
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
- Investments
-
3
Gallus Biopharmaceuticals General Information
Description
Manufacturer and supplier of clinical and commercial bulk biologics to the biopharmaceutical industry in the United States and internationally. The company provides process development, analytical development, process validation, cell banking, stability testing, QA/QC and regulatory support solutions.
Contact Information
Website
www.gallusbiopharma.comCorporate Office
- 4766 La Guardia Drive
- Berkeley, MO 63134
- United States
Corporate Office
- 4766 La Guardia Drive
- Berkeley, MO 63134
- United States
Gallus Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Gallus Biopharmaceuticals Comparisons
Industry
Financing
Details
Gallus Biopharmaceuticals Competitors (6)
One of Gallus Biopharmaceuticals’s 6 competitors is Curia, a Private Equity-Backed company based in Albany, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Curia | Private Equity-Backed | Albany, NY | ||||
| Coriolis Pharma | Venture Capital-Backed | Martinsried, Germany | ||||
| CordenPharma | Private Equity-Backed | Basel, Switzerland | ||||
| Novonesis | Corporation | Lyngby, Denmark | ||||
| Symbiosis Pharmaceutical Services | Venture Capital-Backed | Stirling, United Kingdom |
Gallus Biopharmaceuticals Signals
Gallus Biopharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Gallus Biopharmaceuticals Investments & Acquisitions (3)
Gallus Biopharmaceuticals’s most recent deal was a Buyout/LBO with Laureate Biopharmaceutical Services. The deal was made on 01-Oct-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Laureate Biopharmaceutical Services | 01-Oct-2013 | Buyout/LBO | Pharmaceuticals | ||
| Centocor Biologics (Manufacturing Plant) | 19-May-2011 | Buyout/LBO | Buildings and Property | ||
| Centocor Biologics | 13-May-2011 | Merger/Acquisition | Biotechnology |
Gallus Biopharmaceuticals FAQs
-
When was Gallus Biopharmaceuticals founded?
Gallus Biopharmaceuticals was founded in 2010.
-
Where is Gallus Biopharmaceuticals headquartered?
Gallus Biopharmaceuticals is headquartered in Berkeley, MO.
-
What is the size of Gallus Biopharmaceuticals?
Gallus Biopharmaceuticals has 180 total employees.
-
What industry is Gallus Biopharmaceuticals in?
Gallus Biopharmaceuticals’s primary industry is Biotechnology.
-
Is Gallus Biopharmaceuticals a private or public company?
Gallus Biopharmaceuticals is a Private company.
-
What is the current valuation of Gallus Biopharmaceuticals?
The current valuation of Gallus Biopharmaceuticals is .
-
What is Gallus Biopharmaceuticals’s current revenue?
The current revenue for Gallus Biopharmaceuticals is .
-
Who are Gallus Biopharmaceuticals’s investors?
Ridgemont Equity Partners has invested in Gallus Biopharmaceuticals.
-
Who are Gallus Biopharmaceuticals’s competitors?
Curia, Coriolis Pharma, CordenPharma, Novonesis, and Symbiosis Pharmaceutical Services are some of the 6 competitors of Gallus Biopharmaceuticals.
-
When was Gallus Biopharmaceuticals acquired?
Gallus Biopharmaceuticals was acquired on 30-Sep-2014.
-
Who acquired Gallus Biopharmaceuticals?
Gallus Biopharmaceuticals was acquired by Patheon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process